Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 19 results.
User Information
Export Records
  1. 1.   Viral envelope protein folding and membrane hemifusion are enhanced by the conserved loop region of HIV-1 gp41
  2. Ashkenazi, A.; Viard, M.; Wexler-Cohen, Y.; Blumenthal, R.; Shai, Y.
  3. Faseb Journal. 2011, Jul; 25(7): 2156-2166.
  1. 2.   HYAL1 and HYAL2 Inhibit Tumour Growth In Vivo but Not In Vitro
  2. Wang, F. L.; Grigorieva, E. V.; Li, J. F.; Senchenko, V. N.; Pavlova, T. V.; Anedchenko, E. A.; Kudryavtseva, A. V.; Tsimanis, A.; Angeloni, D.; Lerman, M. I.; Kashuba, V. I.; Klein, G.; Zabarovsky, E. R.
  3. Plos One. 2008, Aug; 3(8): 8.
  1. 3.   A covalent inhibitor targeting an intermediate conformation of the fusogenic subunit of the HIV-1 envelope complex
  2. Jacobs, A.; Quraishi, O.; Huang, X. C.; Bousquet-Gagnon, N.; Nault, G.; Francella, N.; Alvord, W. G.; Pham, N.; Soucy, C.; Robitaille, M.; Bridon, D.; Blumenthal, R.
  3. Journal of Biological Chemistry. 2007, Nov; 282(44): 32406-32413.
  1. 4.   A novel soluble mimic of the glycolipid, globotriaosyl ceramide inhibits HIV infection
  2. Lund, N.; Branch, D. R.; Mylvaganam, M.; Chark, D.; Ma, X. Z.; Sakac, D.; Binnington, B.; Fantini, J.; Puri, Z.; Blumenthal, R.; Lingwood, C.
  3. Aids. 2006, Feb; 20(3): 333-343.
  1. 5.   Potent neutralization of Hendra and Nipah viruses by human monoclonal antibodies
  2. Zhu, Z. Y.; Dimitrov, A. S.; Bossart, K. N.; Crameri, G.; Bishop, K. A.; Choudhry, V.; Mungall, B. A.; Feng, Y. R.; Choudhary, A.; Zhang, M. Y.; Feng, Y.; Wang, L. F.; Xiao, X. D.; Eaton, B. T.; Broder, C. C.; Dimitrov, D. S.
  3. Journal of Virology. 2006, JAN; 80(2): 891-899.
  1. 6.   Regulation of human immunodeficiency virus type 1 envelope glycoprotein fusion by a membrane-interactive domain in the gp41 cytoplasmic tail
  2. Wyss, S.; Dimitrov, A. S.; Baribaud, F.; Edwards, T. G.; Blumenthal, R.; Hoxie, J. A.
  3. Journal of Virology. 2005, OCT; 79(19): 12231-12241.
  1. 7.   Structure-based discovery of a novel angiotensin converting enzyme 2 inhibitor
  2. Huentelman, M. J.; Zubcevic, J.; Prada, J. A. H.; Xiao, X. D.; Dimitrov, D. S.; Raizada, M. K.; Ostrov, D. A.
  3. Hypertension. 2004, DEC; 44(6): 903-906.
  1. 8.   Inhibition of HIV-1 envelope glycoprotein-mediated cell fusion by a DL-amino acid-containing fusion peptide - Possible recognition of the fusion complex
  2. Gerber, D.; Pritsker, M.; Gunther-Ausborn, S.; Johnson, B.; Blumenthal, R.; Shai, Y.
  3. Journal of Biological Chemistry. 2004, NOV 12; 279(46): 48224-48230.
  1. 9.   The SARS-CoV S glycoprotein
  2. Xiao, X.; Dimitrov, D. S.
  3. Cellular and Molecular Life Sciences. 2004, OCT; 61(19-20): 2428-2430.
  1. 10.   Identification of a novel CD4i human monoclonal antibody Fab that neutralizes HIV-1 primary isolates from different clades
  2. Zhang, M. Y.; Shu, Y.; Sidorov, I.; Dimitrov, D. S.
  3. Antiviral Research. 2004 61(3): 161-164.
  1. 11.   Role of the fusion peptide and membrane-proximal dornain in HIV-I envelope glycoprotein-mediated membrane fusion
  2. Dimitrov, A. S.; Rawat, S. S.; Jiang, S.; Blumenthal, R.
  3. Biochemistry. 2003 42(48): 14150-14158.
  1. 12.   Progressive truncations C terminal to the membrane-spanning domain of simian immunodeficiency virus Env reduce fusogenicity and increase concentration dependence of Env for fusion
  2. Lin, X. X.; Derdeyn, C. A.; Blumenthal, R.; West, J.; Hunter, E.
  3. Journal of Virology. 2003 77(12): 7067-7077.
  1. 13.   Access of antibody molecules to the conserved coreceptor binding site on glycoprotein gpl120 is sterically restricted on primary human immunodeficiency virus type 1
  2. Labrijn, A. F.; Poignard, P.; Raja, A.; Zwick, M. B.; Delgado, K.; Franti, M.; Binley, J.; Vivona, V.; Grundner, C.; Huang, C. C.; Venturi, M.; Petropoulos, C. J.; Wrin, T.; Dimitrov, D. S.; Robinson, J.; Kwong, P. D.; Wyatt, R. T.; Sodroski, J.; Burton, D. R.
  3. Journal of Virology. 2003 77(19): 10557-10565.
  1. 14.   The HIV Env-mediated fusion reaction
  2. Gallo, S. A.; Finnegan, C. M.; Viard, M.; Raviv, Y.; Dimitrov, A.; Rawat, S. S.; Puri, A.; Durell, S.; Blumenthal, R.
  3. Biochimica Et Biophysica Acta-Biomembranes. 2003 1614(1): 36-50.
  1. 15.   Broadly cross-reactive HIV-1-neutralizing human monoclonal Fab selected for binding to gp120-CD4-CCR5 complexes
  2. Moulard, M.; Phogat, S. K.; Shu, Y.; Labrijn, A. F.; Xiao, X. D.; Binley, J. M.; Zhang, M. Y.; Sidorov, I. A.; Broder, C. C.; Robinson, J.; Parren, P.; Burton, D. R.; Dimitrov, D. S.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2002 99(10): 6913-6918.
  1. 16.   HIV-1 gp41 six-helix bundle formation occurs rapidly after the engagement of gp120 by CXCR4 in the HIV-1 Env-mediated fusion process
  2. Gallo, S. A.; Puri, A.; Blumenthal, R.
  3. Biochemistry. 2001 40(41): 12231-12236.
  1. 17.   Down-regulation of the chemokine receptor CCR5 by activation of chemotactic formyl peptide receptor in human monocytes
  2. Shen, W. P.; Li, B. Q.; Wetzel, M. A.; Rogers, T. J.; Henderson, E. E.; Su, S. B.; Gong, W. H.; Le, Y. Y.; Sargeant, R.; Dimitrov, D. S.; Oppenheim, J. J.; Wang, J. M.
  3. Blood. 2000 96(8): 2887-2894.
  1. 18.   A mechanism of resistance to HIV-1 entry: Inefficient interactions of CXCR4 with CD4 and gp120 in macrophages
  2. Dimitrov, D. S.; Norwood, D.; Stantchev, T. S.; Feng, Y. R.; Xiao, X. D.; Broder, C. C.
  3. Virology. 1999 259(1): 1-6.
  1. 19.   Three-Dimensional Solution Structure of the 44 Kda Ectodomain of Siv Gp41
  2. Caffrey, M.; Cai, M. L.; Kaufman, J.; Stahl, S. J.; Wingfield, P. T.; Covell, D. G.; Gronenborn, A. M.; Clore, G. M.
  3. Embo Journal. 1998 17(16): 4572-4584.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel